Patent · US Active

Processes for preparing 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

US11312699B2 · kind B2 · utility

0Cited by

13References

24Claims

0Family size

Assignee

CELGENE CORPORATION · US

Inventors

Marie Georges Beauchamps · Dover, US
Gregg Feigelson · Monsey, US
Jianxin Han · Green Brook, US
Joshua Hansen · Village of La Jolla, US
Mohit Atul Kothare · Bound Brook Junction, US
Michael James Williams · Ottawa, US
Michael J. Zacuto · Jersey City, US
Weihong Zhang · Highland Park, US

Key dates

Filing date	Dec 4, 2020
Grant date	Apr 26, 2022
Priority date	—
Expiry date	Dec 4, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Provided herein are processes for preparing 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.